A R T I C L E S
Chaka et al.
metalloenzymes might be the result of a structural entatic (i.e.,
strained) state in which the protein matrix constrains the metal
coordination sphere to adopt a geometry closely approximating
the transition state normally encountered in similar uncon-
strained systems, thereby minimizing the reorganization en-
ergy.3,8 Subsequent structural determinations for several
cupredoxins9-13 have revealed that, in both the oxidized and
reduced forms, the copper exists in a trigonal pyramidal
coordination environment in which two unsaturated nitrogens
(from histidines) and a mercaptide sulfur (cysteine) form the
basal plane with an elongated bond to a thiaether sulfur
(methionine) at the apical position.14,15 In some cupredoxins,
such as azurins, a carbonyl oxygen (from glycine) is coordinated
at the opposite apex to generate a distorted trigonal bipyramidal
coordination sphere which is also maintained in both oxidation
states.11 A related red copper protein has a five-coordinate
copper site exhibiting a square pyramidal coordination geom-
etry.16
doxins are primarily attributable to the covalent nature of the
Cu-S(mercaptide) bond in the basal plane of the active site.
They also found that the electronic effects arising from this
strong Cu-S bond give rise to the unusual geometry associated
with the type-1 Cu site and also facilitate rapid electron transfer.
The Cu atom can thus be viewed as existing in an electronic
entatic state rather than a simple geometric constraint physically
imposed upon the active site by the protein matrix.
The question remains as to whether geometric constraints
alone can lead to rapid electron transfer in CuII/I systems. Several
attempts have been reported in the literature, by Stanbury19-23
and others,24,25 to generate CuII/I complexes maintaining nearly
constant geometries in both oxidation states. To date, none of
these systems have yielded CuII/I self-exchange rate constants
comparable to those exhibited by the rapidly reacting cupre-
doxins, and some have, in fact, yielded extremely small k11
values.19,20 By contrast, of the inorganic copper complexes that
26-30
have been reported to exhibit the largest k11 values,
all
Both Solomon17 and Ryde18 and their co-workers have carried
out theoretical calculations from which they concluded the
spectral properties and electron-transfer kinetics of the cupre-
but one30 involve the rupture of a single Cu-S(thiaether) bond
upon reduction, a geometric change that is apparently quite
facile.
(7) (a) Sisley, M. J.; Jordan, R. B. Inorg. Chem. 1992, 31, 2880-2884. (b)
Irangu, J.; Ferguson, M. J.; Jordan, R. B. Inorg. Chem. 2005, 44, 1619-
1625.
In the current investigation, we have generated a quinque-
dentate ligand incorporating three thiaether sulfurs and a
bipyridine moiety within a macrocyclic structure, namely, cyclo-
6,6′-[1,9-(2,5,8-trithianonane)]-2,2′-bipyridine ([15]aneS3bpy )
L).31 The coordination geometry of the oxidized complex, [CuII-
(8) Williams, R. J. P. Inorg. Chim. Acta ReV. 1971, 5, 137-155. Compare:
Williams, R. J. P. Eur. J. Biochem. 1995, 234, 363-381.
(9) Colman, P. M.; Freeman, H. C.; Guss, J. M.; Murata, M.; Norris, V. A.;
Ramshaw, J. A. M.; Venkatappa, M. P. Nature 1978, 272, 319-324.
(10) Plastocyanins: (a) Guss, J. M.; Freeman, H. C. J. Mol. Biol. 1983, 169,
521-563. (b) Guss, J. M.; Harrowell, P. R.; Murata, M.; Norris, V. A.;
Freeman, H. C. J. Mol. Biol. 1986, 192, 361-387. (c) Collyer, C. A.; Guss,
J. M.; Sugimura, Y.; Yoshizaki, F.; Freeman, H. C. J. Mol. Biol. 1990,
211, 617-632. (d) Guss, J. M.; Bartunik, H. D.; Freeman, H. C. Acta
Crystallogr., Sect. B 1992, 48, 790-811. (e) Fields, B. A.; Bartsch, H. H.;
Bartunik, H. D.; Cordes, F.; Guss, J. M.; Freeman, H. C. Acta Crystallogr.,
Sect. D 1994, 50, 709-730. (f) Bond, C. S.; Bendall, D. S.; Freeman, H.
C.; Guss, J. M.; Howe, C. J.; Wagner, M. J.; Wilce, M. C. J. Acta
Crystallogr., Sect. D 1999, 55, 414-421.
(11) Azurins: (a) Baker, E. N. J. Mol. Biol. 1988, 203, 1071-1095. (b) Shepard,
W. E. B.; Anderson, B. F.; Lewandowski, D. A.; Norris, G. E.; Baker, E.
N. J. Am. Chem. Soc. 1990, 112, 7817-7819. (c) Nar, H.; Messerschmidt,
A.; Huber, R.; van de Kamp, M.; Canters, G. W. J. Mol. Biol. 1991, 221,
765-772. (d) Li, C. M.; Inoue, T.; Gotowda, M.; Suzuki, S.; Yamaguchi,
K.; Kai, K.; Kai, Y. Acta Crystallogr., Sect. D 1998, 54, 347-354. (e)
Dodd, F. E.; Abraham, Z. H. L.; Eady, R. R.; Hasnain, S. S. Acta
Crystallogr., Sect. D 2000, 56, 690-696.
([15]aneS3bpy)]2+, is square pyramidal, paralleling the geometry
of two rapidly reacting macrocyclic complexes, [CuII([15]-
(18) (a) Olsson, M. H. M.; Ryde, U.; Roos, B. O. Protein Sci. 1998, 7, 2659-
2668. (b) De Kerpel, J. O. A.; Ryde, U. Proteins: Struct., Func., Genet.
1999, 36, 157-174. (c) Ryde, U.; Olsson, M. H. M.; Roos, B. O.; De
Kerpel, J. O. A.; Pierloot, K. J. Biol. Inorg. Chem. 2000, 5, 565-574. (d)
Ryde, U.; Olsson, M. H. M. Int. J. Quantum Chem. 2001, 81, 335-347.
(e) Ryde, U.; Olsson, M. H. M.; Roos, B. O.; Borin, A. C. Theor. Chem.
Acc. 2001, 105, 452-462. (f) Sigfridsson, E.; Olsson, M. H. M.; Ryde, U.
J. Phys. Chem. B 2001, 105, 5546-5552.
(12) Stellacyanin: Hart, P. J.; Nersissian, A. M.; Herrmann, R. G.; Nalbandyan,
R. M.; Valentine, J. S.; Eisenberg, D. Protein Sci. 1996, 5, 2175-2183.
(13) Other cupredoxins: (a) Pseudozaurin: Petratos, K.; Dauter, Z.; Wilson,
K. S. Acta Crystallogr., Sect. B 1988, 44, 628-636. (b) Phytocyanin
(cucumber blue protein): Guss, J. M.; Merritt, E. A.; Phizackerley, R. P.;
Freeman, H. C. J. Mol. Biol. 1996, 262, 686-705. Cf., Guss, J. M.; Merritt,
E. A.; Phizackerley, R. P.; Hedman, B.; Murata, M.; Hodgson, K. O.;
Freeman, H. C. Science 1988, 241, 806-811. (c) Rusticyanin: Harvey, I.;
Hao, Q.; Duke, E. M. H.; Ingledew, W. J.; Hasnain, S. S. Acta Crystallogr.,
Sect. D 1998, 54, 629-635. (d) Plantacyanin: Einsle, O.; Mehrabian, Z.;
Nalbandyan, R.; Messerschmidt, A. J. Biol. Inorg. Chem. 2000, 5, 666-
672. (e) Amicyanin: Mukherjee, M.; Maiti, S.; Ghosh, S.; Woolfson, M.
M. Acta Crystallogr., Sect. D 2001, 57, 1276-1280. (f) Auracyanin: Bond,
C. S.; Blankenship, R. E.; Freeman, H. C.; Guss, J. M.; Maher, M. J.;
Selvaraj, F. M.; Wilce, M. C. J.; Willingham, K. M. J. Mol. Biol. 2001,
306, 47-67. Cf., Lee, M.; Maher, M. J.; Freeman, H. C.; Guss, J. M. Acta
Crystallogr., Sect. D 2003, 59, 1545-1550.
(19) Xie, B.; Elder, T.; Wilson, L. J.; Stanbury, D. M. Inorg. Chem. 1999, 38,
12-19.
(20) Xie, B.; Wilson, L. J.; Stanbury, D. M. Inorg. Chem. 2001, 40, 3606-
3614.
(21) Goodwin, J. A.; Stanbury, D. M.; Wilson, L. J.; Eigenbrot, C. W.; Scheidt,
W. R. J. Am. Chem. Soc. 1987, 109, 2979-2991.
(22) Goodwin, J. A.; Wilson, L. J.; Stanbury, D. M.; Scott, R. A. Inorg. Chem.
1989, 28, 42-50.
(23) Coggin, D. K.; Gonza´lez, J. A.; Kook, A. M.; Bergman, C.; Brennan, T.
D.; Scheidt, W. R.; Stanbury, D. M.; Wilson, L. J. Inorg. Chem. 1991, 30,
1125-1134.
(24) Metelski, P. D.; Hinman, A. S.; Takagi, H. D.; Swaddle, T. W. Can. J.
Chem. 1995, 73, 61-69.
(14) Adman, E. T. AdV. Protein Chem. 1991, 42, 145-197.
(15) In stellacyanin, a glutamine oxygen occupies the apical site; see ref 12.
(16) Lieberman, R. L.; Arciero, D. M.; Hooper, A. B.; Rosenzweig, A. C.
Biochemistry 2001, 40, 5674-5681.
(25) McMaster, J.; Beddoes, R. L.; Collison, D.; Eardley, D. R.; Helliwell, M.;
Garner, C. D. Chem. Eur. J. 1996, 2, 685-693.
(26) Vande Linde, A. M. Q.; Juntunen, K. L.; Mols, O.; Ksebati, M. B.;
Ochrymowycz, L. A.; Rorabacher, D. B. Inorg. Chem. 1991, 30, 5037-
5042.
(17) (a) Solomon, E. I.; Lowery, M. D. Science 1993, 259, 1575-1581. (b)
Guckert, J. A.; Lowery, M. D.; Solomon, E. I. J. Am. Chem. Soc. 1995,
117, 2817-2844. (c) Solomon, E. I.; Penfield, K. W.; Gewirth, A. A.;
Lowery, M. D.; Shadle, S. E.; Guckert, J. A.; LaCroix, L. B. Inorg. Chim.
Acta 1996, 243, 67-78. (d) Solomon, E. I.; LaCroix, L. B.; Randall, D.
W. Pure Appl. Chem. 1998, 70, 799-808. (e) Solomon, E. I.; Lowery, M.
D.; Guckert, J. A.; LaCroix, L. B. In Electron Transfer Reactions; Advances
in Chemistry Series, Vol. 253; American Chemical Society: Washington,
DC, 1997; pp 317-330. (f) Randall, D. W.; Gamelin, D. R.; LaCroix, L.
B.; Solomon, E. I. J. Biol. Inorg. Chem. 2000, 5, 16-29. (g) Randall, D.
W.; George, S. D.; Hedman, B.; Hodgson, K. O.; Fujisawa, K.; Solomon,
E. I. J. Am. Chem. Soc. 2000, 122, 11620-11631. (h) Solomon, E. I.;
Szilagyi, R. K,; George, S. D.; Basumallick, L. Chem. ReV. 2004, 104,
419-458.
(27) Vande Linde, A. M. Q.; Westerby, B. C.; Ochrymowycz, L. A.; Rorabacher,
D. B. Inorg. Chem. 1993, 32, 251-257.
(28) Krylova, K.; Kulatilleke, C. P.; Heeg, M. J.; Salhi, C. A.; Ochrymowycz,
L. A.; Rorabacher, D. B. Inorg. Chem. 1999, 38, 4322-4328.
(29) Leggett, G. H.; Dunn, B. C.; Vande Linde, A. M. Q.; Ochrymowycz, L.
A.; Rorabacher, D. B. Inorg. Chem. 1993, 32, 5911-5918.
(30) Pulliam, E. J.; McMillin, D. R. Inorg. Chem. 1984, 23, 1172-1175: TAAB
) tetrabenzo[b,f,j,n]-[1,5,9,13]tetraazacyclohexadecine.
(31) This ligand can also be designated as 2,5,8[9](6,6′)2,2′-bipyridinophane
based on the nomenclature adopted by Weber and Vo¨gtle for similar
macrocyclic ligands containing pyridines and thiaether sulfurs: Weber, E.;
Vo¨gtle, F. Liebigs Ann. Chem. 1976, 891-915.
9
5218 J. AM. CHEM. SOC. VOL. 129, NO. 16, 2007